- Integrated EEG Platform: A seamless end-to-end solution for data collection and analysis, merging Neuroelectrics’ wireless EEG systems with Neuronostics’ advanced analytics.
- Enhanced Trial Efficiency: Targeted participant selection and robust digital biomarkers to optimize study outcomes while reducing costs and timelines.
- Transformative Solutions: Customizable packages designed for pharmaceutical and medical device companies conducting neurological clinical trials.
Barcelona, December 2024 — Neuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored for the pharmaceutical, contract research organizations (CROs) and academic partners. This collaboration combines Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research.
A Game-Changing Collaboration
The partnership addresses a critical need in clinical trials for high-quality, actionable data by providing an integrated platform that accelerates research and improves outcomes. Leveraging Neuronostics’ proprietary BioEP tool and Neuroelectrics’ premium EEG technology, the platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are both efficient and impactful.
John Terry, Managing Director at Neuronostics, stated:
“This collaboration with Neuroelectrics creates a powerful offering that will enable EEG and digital biomarkers to make clinical trials more efficient and effective, leading to significant benefits for people with neurological conditions.”
Ana Maiques, CEO of Neuroelectrics, commented:
“At Neuroelectrics, we believe in advancing brain health through innovation. Our partnership with Neuronostics elevates clinical trials by integrating the best in EEG technology and analytics, enabling breakthroughs in neurology and psychiatry.
The Power of Integrated EEG Solutions
Targeted Cohort Identification: The integrated EEG tool assists in identifying participants with the highest seizure burden through a brief 20-minute EEG. This targeted approach saves time and enhances statistical significance in trials.
Comprehensive Data Analysis: Certified neurophysiologists combine clinical expertise with Neuronostics’ cloud-based digital tools to deliver robust, actionable EEG insights tailored to trial objectives.
Optimized Protocol Design: Experts collaborate with sponsors to create trial protocols aligned with study goals, ensuring streamlined processes and reliable results.
About Neuronostics
Neuronostics specializes in accelerating clinical trials with advanced EEG solutions, providing pharmaceutical and medical device companies with tools to optimize participant selection, protocol design, and data analysis. Their proprietary BioEP tool and expert clinical insights transform traditional approaches, enabling faster, more cost-effective research.
About Neuroelectrics
Neuroelectrics products are being used worldwide for both neuroscience and clinical research in hundreds of universities and academic medical centers. Their vision is to create a powerful neurotechnology platform upon which verticals can be developed to improve the lives of as many people as possible.
